Major League Baseball and the Major League Baseball Players Association on Monday released the annual public report from the Joint Drug Prevention and Treatment Program’s independent program administrator, Dr. Thomas M. Martin.

The 2025 reporting period produced two positive tests among players on 40-man rosters. Both were for performance-enhancing substances.

In all, 11,700 tests were conducted during the reporting period, which ranged from the start of last offseason through the end of this year’s postseason. These included 9,400 urine samples that were analyzed for performance-enhancing substances, stimulants, DHEA, diuretics, masking agents and drugs of abuse, and 2,300 blood samples that were analyzed for the presence of human growth hormone.

More than 23,000 total tests have been

See Full Page